SecBot SecBot
Insider Cluster (2 insiders) ·Filed Nov 10, 2026

ATRC

AtriCure, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed6d 10h ago
Insider cluster: 2 insiders, $690K total
Actionable Insight • Neutral

The dollar amount is too small relative to market cap to signal a material change in insider sentiment. The CTO's sale under a 10b5-1 plan is routine. Monitor next Form 4 filings for any larger or non-plan sales by C-suite executives.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1
Entry
$57.53
T+0 close · Nov 10, 2026 · via day close
Latest settled
−2.69%
T+1 · $55.98
Vs SPY
−2.34%
α at T+1
Next horizon
T+5
tomorrow
  1. T+0 · Nov 11 $57.53entry
  2. T+1 · 5d ago −2.69%α −2.34% · $55.98
  3. T+3 · todayOpen
  4. T+5 · tomorrow Pending
  5. T+20 · in 23d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two AtriCure insiders sold a combined $690K in open-market sales within a week of the company's strong Q3 earnings beat and raised guidance. The CTO's sale was under a 10b5-1 plan, while the director's sale was not. The total value is 0.023% of market cap, which is trivial relative to company size.

Key Financial Metrics

Direction
selling
Total Value
$689.7K
Insiders
2

Key Facts

  • Director B. Kristine Johnson sold 2,452 shares at $58.48 for $143K on 2026-11-06 (no 10b5-1 plan)
  • CTO Salvatore Privitera sold 8,404 shares at $65.00 for $546K on 2026-11-04 (10b5-1 plan)
  • Total open-market sales: $689,653 (0.023% of $3.0B market cap)
  • Sales occurred 1-3 days after Q3 2026 earnings beat and raised guidance (filed 2026-11-03)

Financial Impact

Total insider sales of $690K, representing 0.023% of market cap

Risk Factors

  • Director Johnson's sale without a 10b5-1 plan could indicate personal portfolio rebalancing, but the amount is immaterial
  • No risk of material insider-driven signal given the trivial size relative to market cap

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
73% bullish (15 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ATRC-1794344605339

Track record

19 reports on ATRC

Performance horizon

2 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +89.53% at T+60 after the Jun 14, 2026 report. 3 of 5 went positive at some point.

Filters
  1. Nov 16, 2026today Institutional Cluster Mixed 3/10 Entry $55.42 Now $55.31 −0.20% settles Feb 12
  2. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $55.72 Now $55.31 −0.74% settles Feb 12
  3. Nov 10, 20266d ago Insider Cluster Neutral 2/10 Viewing Entry $57.53 Now $55.31 −3.86% settles Feb 9
  4. Nov 6, 202610d ago 144 Neutral 2/10 Entry $57.78 Now $55.31 −4.27% settles Feb 5
  5. Nov 6, 202610d ago Institutional Cluster Bullish 4/10 Entry $58.54 Now $55.31 −5.52% settles Feb 4
  6. Nov 4, 202612d ago 144 Neutral 2/10 Entry $61.28 Now $55.31 −9.74% settles Feb 3
  7. Nov 3, 202613d ago 8-K Bullish 6/10 Entry $65.53 Now $55.31 −15.60% settles Feb 2
  8. Oct 30, 202617d ago SC 13G/A Neutral 2/10 Entry $61.25 Now $55.31 −9.70% settles Jan 28
  9. Oct 5, 20266w ago SC 13G/A Neutral 3/10 Entry $56.37 Now $55.31 −1.88% settles Dec 30
  10. Sep 14, 20269w ago Insider Cluster Neutral 2/10 Entry $56.22 Now $55.31 −1.62% settles Dec 9
Showing 10 of 19

US Market Status

Market Closed · Opens in 7h 3m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 10, 2026